We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
+9.67%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$42.6B
AUM Growth
-$927M
(-2.1%)
Cap. Flow
-$4.42B
Cap. Flow
% of AUM
-10.38%
Top 10 Holdings %
Top 10 Hldgs %
9.02%
Holding
3,518
New
408
Increased
1,022
Reduced
1,392
Closed
532
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$244M |
| 2 |
Pfizer
PFE
|
+$234M |
| 3 |
Nike
NKE
|
+$201M |
| 4 |
Tesla
TSLA
|
+$200M |
| 5 |
S&P Global
SPGI
|
+$196M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$305M |
| 2 |
Advanced Micro Devices
AMD
|
+$241M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$231M |
| 4 |
Merck
MRK
|
+$199M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.1% |
| 2 | Healthcare | 11.63% |
| 3 | Consumer Discretionary | 11.09% |
| 4 | Financials | 10.76% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Tactile Systems Technology
TCMD
$665M
| $315K | ﹤0.01% |
19,368
-13,200
| -41% | -$200K |
|
|
RPTX
2502
DELISTED
Repare Therapeutics
RPTX
| $314K | ﹤0.01% |
66,753
+41,277
| +162% | +$264K |
|
2503
Wahed FTSE USA Shariah ETF
HLAL
$956M
| $314K | ﹤0.01% |
6,500
+1,600
| +33% | +$74.9K |
|
2504
Trustmark
TRMK
$2.75B
| $313K | ﹤0.01% |
11,152
-25,009
| -69% | -$675K |
|
2505
Resideo Technologies
REZI
$3.95B
| $313K | ﹤0.01% |
13,948
-237,242
| -94% | -$4.69M |
|
2506
VanEck Steel ETF
SLX
$176M
| $312K | ﹤0.01% |
+4,300
| New | +$302K |
|
2507
Invesco S&P Ultra Dividend Revenue ETF
RDIV
$1.39B
| $312K | ﹤0.01% |
+6,800
| New | +$296K |
|
2508
Mid Penn Bancorp
MPB
$952M
| $311K | ﹤0.01% |
15,530
-848
| -5% | -$18.3K |
|
2509
Artesian Resources
ARTNA
$358M
| $310K | ﹤0.01% |
8,365
-5,212
| -38% | -$190K |
|
|
HTT
2510
High Templar Tech Ltd
HTT
$391M
| $309K | ﹤0.01% |
123,594
+47,883
| +63% | +$110K |
|
2511
Northrim BanCorp
NRIM
$587M
| $308K | ﹤0.01% |
24,412
-4,400
| -15% | -$55.6K |
|
2512
VictoryShares US Small Cap High Div Volatility Wtd ETF
CSB
$266M
| $308K | ﹤0.01% |
+5,500
| New | +$296K |
|
2513
Brunswick
BC
$5.28B
| $308K | ﹤0.01% |
3,191
-15,900
| -83% | -$1.4M |
|
2514
Cogent Communications
CCOI
$508M
| $307K | ﹤0.01% |
4,703
-7,597
| -62% | -$555K |
|
2515
Virgin Galactic
SPCE
$398M
| $306K | ﹤0.01% |
10,349
-47,927
| -82% | -$1.74M |
|
2516
AN2 Therapeutics
ANTX
$214M
| $306K | ﹤0.01% |
94,168
+74,920
| +389% | +$815K |
|
2517
CEL-SCI Corp
CVM
$30.1M
| $305K | ﹤0.01% |
5,317
+1,965
| +59% | +$139K |
|
2518
Park Aerospace
PKE
$819M
| $303K | ﹤0.01% |
18,195
-7,505
| -29% | -$111K |
|
|
MACK
2519
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $301K | ﹤0.01% |
20,401
-1,433
| -7% | -$20.1K |
|
2520
Range Resources
RRC
$8.95B
| $300K | ﹤0.01% |
8,709
-55,191
| -86% | -$1.71M |
|
2521
TScan Therapeutics
TCRX
$52M
| $300K | ﹤0.01% |
+37,747
| New | +$237K |
|
2522
MarineMax
HZO
$788M
| $299K | ﹤0.01% |
9,000
-33,589
| -79% | -$1.08M |
|
2523
ACNB Corp
ACNB
$655M
| $299K | ﹤0.01% |
7,944
+1,043
| +15% | +$40.6K |
|
2524
Douglas Elliman
DOUG
$162M
| $299K | ﹤0.01% |
189,040
+27,515
| +17% | +$56.3K |
|
2525
Upbound Group
UPBD
$1.16B
| $297K | ﹤0.01% |
8,431
-6,400
| -43% | -$214K |
|
Similar funds
VAM
Two Sigma Investments's Q1 2024 Portfolio in Review
As of Q1 2024, Two Sigma Investments held 3,518 positions worth $42.6B, down 2.1% from $43.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Two Sigma Investments withdrew a net $4.42B in Q1 2024, closing 532 positions and reducing 1,392 holdings. Its most notable exit was Rivian, an estimated $158M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Two Sigma Investments opened a new position in Pfizer worth $234M.
- Two Sigma Investments's largest Q1 2024 buy was Pfizer: 8,419,014 shares worth $234M.
- Two Sigma Investments added most to Gilead Sciences in Q1 2024, an estimated $244M increase.
- Two Sigma Investments's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $305M.
- Two Sigma Investments fully exited Rivian in Q1 2024, selling an estimated $158M.
- Two Sigma Investments's ten largest holdings make up 9% of its $42.6B portfolio in Q1 2024.
- Two Sigma Investments opened 408 new positions and closed 532 in Q1 2024.
- Two Sigma Investments's portfolio value fell 2.1% quarter-over-quarter to $42.6B.
Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.